306 related articles for article (PubMed ID: 21903862)
21. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?
van Raalte DH; Ouwens DM; Diamant M
Eur J Clin Invest; 2009 Feb; 39(2):81-93. PubMed ID: 19200161
[TBL] [Abstract][Full Text] [Related]
22. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
De Bosscher K; Beck IM; Haegeman G
Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
[TBL] [Abstract][Full Text] [Related]
23. Changes in human placental 5alpha-reductase isoenzyme expression with advancing gestation: effects of fetal sex and glucocorticoid exposure.
Vu TT; Hirst JJ; Stark M; Wright IM; Palliser HK; Hodyl N; Clifton VL
Reprod Fertil Dev; 2009; 21(4):599-607. PubMed ID: 19383266
[TBL] [Abstract][Full Text] [Related]
24. Steroid 5α-reductase in adult rat brain after neonatal testosterone administration.
Sánchez P; Torres JM; del Moral RG; de Dios Luna J; Ortega E
IUBMB Life; 2012 Jan; 64(1):81-6. PubMed ID: 22131296
[TBL] [Abstract][Full Text] [Related]
25. Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.
Meduri GU; Yates CR
Ann N Y Acad Sci; 2004 Jun; 1024():24-53. PubMed ID: 15265772
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid-recognizing and -effector sites in rat liver plasma membrane. Kinetics of corticosterone uptake by isolated membrane vesicles. III. Specificity and stereospecificity.
Lackner C; Daufeldt S; Wildt L; Alléra A
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):69-82. PubMed ID: 9569012
[TBL] [Abstract][Full Text] [Related]
27. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
Löwenberg M; Stahn C; Hommes DW; Buttgereit F
Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
[TBL] [Abstract][Full Text] [Related]
28. 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes.
Nasiri M; Nikolaou N; Parajes S; Krone NP; Valsamakis G; Mastorakos G; Hughes B; Taylor A; Bujalska IJ; Gathercole LL; Tomlinson JW
Endocrinology; 2015 Aug; 156(8):2863-71. PubMed ID: 25974403
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and local anti-inflammatory activity of 17β-carboxamide derivatives of glucocorticoids.
Dobričić V; Marković B; Milenković N; Savić V; Jaćević V; Rančić N; Vladimirov S; Cudina O
Arch Pharm (Weinheim); 2014 Nov; 347(11):786-97. PubMed ID: 25159891
[TBL] [Abstract][Full Text] [Related]
30. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
McMaster A; Ray DW
Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619
[TBL] [Abstract][Full Text] [Related]
31. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma.
Umland SP; Schleimer RP; Johnston SL
Pulm Pharmacol Ther; 2002; 15(1):35-50. PubMed ID: 11969362
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoids: do we know how they work?
Saklatvala J
Arthritis Res; 2002; 4(3):146-50. PubMed ID: 12010562
[TBL] [Abstract][Full Text] [Related]
33. Mitogen-activated protein kinase kinase 1/extracellular signal-regulated kinase (MEK-1/ERK) inhibitors sensitize reduced glucocorticoid response mediated by TNFalpha in human epidermal keratinocytes (HaCaT).
Onda K; Nagashima M; Kawakubo Y; Inoue S; Hirano T; Oka K
Biochem Biophys Res Commun; 2006 Dec; 351(1):266-72. PubMed ID: 17054908
[TBL] [Abstract][Full Text] [Related]
34. [New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].
Huisman AM; Jacobs JW; Buttgereit F; Bijlsma JW
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):476-80. PubMed ID: 16553045
[TBL] [Abstract][Full Text] [Related]
35. 5α-reduced glucocorticoids exhibit dissociated anti-inflammatory and metabolic effects.
Yang C; Nixon M; Kenyon CJ; Livingstone DE; Duffin R; Rossi AG; Walker BR; Andrew R
Br J Pharmacol; 2011 Nov; 164(6):1661-71. PubMed ID: 21542833
[TBL] [Abstract][Full Text] [Related]
36. Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin.
Latif SA; Pardo HA; Hardy MP; Morris DJ
Mol Cell Endocrinol; 2005 Nov; 243(1-2):43-50. PubMed ID: 16188377
[TBL] [Abstract][Full Text] [Related]
37. New evidence of similarity between human and plant steroid metabolism: 5alpha-reductase activity in Solanum malacoxylon.
Rosati F; Danza G; Guarna A; Cini N; Racchi ML; Serio M
Endocrinology; 2003 Jan; 144(1):220-9. PubMed ID: 12488348
[TBL] [Abstract][Full Text] [Related]
38. Genomic and nongenomic effects of glucocorticoids.
Stahn C; Buttgereit F
Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice.
Kleiman A; Tuckermann JP
Mol Cell Endocrinol; 2007 Sep; 275(1-2):98-108. PubMed ID: 17587493
[TBL] [Abstract][Full Text] [Related]
40. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
